509 related articles for article (PubMed ID: 14766296)
1. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
Zhou Y; Singh BR
Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
[TBL] [Abstract][Full Text] [Related]
2. Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A.
Sharma S; Zhou Y; Singh BR
Protein Expr Purif; 2006 Feb; 45(2):288-95. PubMed ID: 16143544
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification and characterization of the receptor-binding domain of botulinum neurotoxin serotype B as a vaccine candidate.
Ben David A; Torgeman A; Barnea A; Zichel R
Protein Expr Purif; 2015 Jun; 110():122-9. PubMed ID: 25727047
[TBL] [Abstract][Full Text] [Related]
4. Cloning, high level expression, purification, and crystallization of the full length Clostridium botulinum neurotoxin type E light chain.
Agarwal R; Eswaramoorthy S; Kumaran D; Dunn JJ; Swaminathan S
Protein Expr Purif; 2004 Mar; 34(1):95-102. PubMed ID: 14766304
[TBL] [Abstract][Full Text] [Related]
5. Cloning, high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E.
Mansour AA; Mousavi SL; Rasooli I; Nazarian S; Amani J; Farhadi N
Biologicals; 2010 Mar; 38(2):260-4. PubMed ID: 19879159
[TBL] [Abstract][Full Text] [Related]
6. Characterization of LC-HCC fusion protein of botulinum neurotoxin type A.
Singh MK; Dhaked RK; Singh P; Gupta P; Singh L
Protein Pept Lett; 2011 Mar; 18(3):295-304. PubMed ID: 21054265
[TBL] [Abstract][Full Text] [Related]
7. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and characterization of Clostridium botulinum type B light chain.
Gilsdorf J; Gul N; Smith LA
Protein Expr Purif; 2006 Apr; 46(2):256-67. PubMed ID: 16297638
[TBL] [Abstract][Full Text] [Related]
10. Deletion mutant comprising 198 residues of BoNT/A toxin receptor binding domain retained gt1b binding property but failed to induce protective antibody response in a mouse model.
Singh MK; Gupta G; Boopathi M; Gupta P; Chauhan V; Tomar A; Singh L; Dhaked RK
Protein Pept Lett; 2012 May; 19(5):530-7. PubMed ID: 22486648
[TBL] [Abstract][Full Text] [Related]
11. High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.
Dhaliwal HK; Thiruvanakarasu N; Kumar R; Patel K; Ambrin G; Cai S; Singh BR
Protein J; 2017 Dec; 36(6):489-501. PubMed ID: 29030733
[TBL] [Abstract][Full Text] [Related]
12. Improved soluble expression and characterization of the Hc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli by using a PCR-synthesized gene and a Trx co-expression strain.
Chen R; Shi J; Cai K; Tu W; Hou X; Liu H; Xiao L; Wang Q; Tang Y; Wang H
Protein Expr Purif; 2010 May; 71(1):79-84. PubMed ID: 19932180
[TBL] [Abstract][Full Text] [Related]
13. Recombinant expression and purification of the botulinum neurotoxin type A translocation domain.
Lacy DB; Stevens RC
Protein Expr Purif; 1997 Nov; 11(2):195-200. PubMed ID: 9367816
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
Jin R; Rummel A; Binz T; Brunger AT
Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
[TBL] [Abstract][Full Text] [Related]
15. Binding activity and immunogenic characterization of recombinant C-terminal quarter and half of the heavy chain of botulinum neurotoxin serotype A.
Yu YZ; Ma Y; Chen YX; Gong ZW; Wang S; Yu WY; Sun ZW
Hum Vaccin; 2011 Oct; 7(10):1090-5. PubMed ID: 21941093
[TBL] [Abstract][Full Text] [Related]
16. [Effective expression of fragments of a botulinum neurotoxin type A gene, coding for the L-chain and H-chain in E. coli, with formation of products causing protective immunity to administration of the toxin].
Vertiev IuV; Zdanovskiĭ AG; Borinskaia SA; Martin T; Gening EL; Iankovskiĭ NK
Mol Gen Mikrobiol Virusol; 2000; (4):3-7. PubMed ID: 11186457
[TBL] [Abstract][Full Text] [Related]
17. High-level expression, purification, and characterization of recombinant type A botulinum neurotoxin light chain.
Li L; Singh BR
Protein Expr Purif; 1999 Dec; 17(3):339-44. PubMed ID: 10600450
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the functional activity of botulinum neurotoxin subtype B6.
Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
[TBL] [Abstract][Full Text] [Related]
19. Production of serotype C specific and serotype C/D generic monoclonal antibodies using recombinant H(C) and H(N) fragments from Clostridium botulinum neurotoxin types C(1) and D.
Curran RM; Fringuelli E; Graham D; Elliott CT
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):1-10. PubMed ID: 19233482
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
